Is AMH Prediction of Menopause?
https://doi.org/10.33667/2078-5631-2023-3-37-41
Abstract
Anti-Müllerian Hormone (AMH) is produced by small antral follicles and has evolved over the past three decades as an assumed potential marker of the number of follicles in the human ovaries, also known as ovarian reserve. This quantitative measure, given the gradual decline over time and its non-replenishable feature, could be the dreamed marker for predicting the fnal exhaustion of ovarian storage: the post-menopause. This introductory chapter summarizes current knowledge with regard to the contribution of serum AMH measurements to predict age of normal menopause and critically discuss its potential in this regard. Furthermore, its predictive role in the context of menopause in association with several frequently occurring fertility disorders such as premature menopause, polycystic ovarian syndrome and endometriosis are discussed. Overall, while ovarian reserve markers including AMH are unmistakably related to age at menopause, they are insuffciently precise to inform on an individual’s journey of ovarian aging.
About the Author
Ya. Z. Zaydieva
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation
Russian Federation
Zaydieva Yana Z., DM Sci (habil.), professor.
References
1. Weinstein M., Gorrindo T., Riley A., Mormino J., Niedfeldt J., Singer B. Timing of Menopause and Patterns of Menstrual Bleeding. Am. J. Epidemiol (2003). 158:782–91. DOI: 10.1093/aje/kwg223
2. Broekmans F. J., Kwee J., Hendriks D. J., Mol B. W., Lambalk C. B. A Systematic Review of Tests Predicting Ovarian Reserve and IVF Outcome. Hum. Reprod. Update (2006). 12:685–718. DOI: 10.1093/humupd/dml034
3. Dolleman M., Depmann M., Eijkemans M.J., Heimensem J., Broer S.L., van der Stroom E.M. Anti-Mullerian Hormone Is a More Accurate Predictor of Individual Time to Menopause Than Mother’s Age at Menopause. Hum. Reprod. (2014). 29:584–91. DOI: 10.1093/humrep/det446
4. Depmann M., Broer S. L., van der Schouw Y. T., Tehrani F. R., Eijkemans MJ., Mol B.W. Can We Predict Age at Natural Menopause Using Ovarian Reserve Tests or Mother’s Age at Menopause? A Systematic Literature Review. Menopause (2016). 23(2):224–32. DOI: 10.1097/GME.0000000000000509
5. Sowers M. R., McConnell D., Yosef M., Jannausch M. L., Harlow S. D., Randolph J.F. Relating Smoking, Obesity, Insulin Resistance, and Ovarian Biomarker Changes to the Final Menstrual Period. Ann. NY Acad. Sci. (2010). 1204:95–103. DOI: 10.1111/j.1749–6632.2010.05523.x
6. Tehrani F.R., Shakeri N., Solaymani-Dodaran M., Azizi F. Predicting Age at Menopause From Serum Antimullerian Hormone Concentration. Menopause (2011). 18:766–70. DOI: 10.1097/gme.0b013e318205e2ac
7. Broer S. L., Eijkemans M. J., Scheffer G. J., van Rooij I. A., de Vet A., Themmen A.P. Anti-Mullerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women. J. Clin. Endocrinol. Metab. (2011). 96:2532–9. DOI: 10.1210/jc.2010–2776
8. Freeman E.W., Sammel M.D., Lin H., Boorman D.W., Gracia C.R. Contribution of the Rate of Change of Antimullerian Hormone in Estimating Time to Menopause for Late Reproductive-Age Women. Fertil. Steril. (2012). 98:1254–9.e1. DOI: 10.1016/j.fertnstert.2012.07.1139
9. Tehrani F.R., Solaymani-Dodaran M., Tohidi M., Gohari M.R., Azizi F. Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone. J. Clin. Endocrinol. Metab. (2013). 98:729–35. DOI: 10.1210/jc.2012–3176
10. Depmann M., Eijkemans M.J.C., Broer S.L., Tehrani F.R., Solaymani-Dodaran M., Azizi F. Does AMH Relate to Timing of Menopause? Results of an Individual Patient Data Meta- Analysis. J. Clin. Endocrinol. Metab. (2018). 103(10):3593–600. DOI:10.1016/j.maturitas.2017.03.325
11. de Kat A.C., van der Schouw Y.T., Eijkemans M.J.C., Broer S.L., Verschuren W.M.M., Broekmans F.J.M. Can Menopause Prediction Be Improved With Multiple AMH Measurements? Results From the Prospective Doetinchem Cohort Study. J. Clin. Endocrinol. Metab. (2019). 104:5024–31. DOI: 10.1210/jc.2018–02607
12. Ramezani Tehrani F., Bidhendi Yarandi R., Solaymani-Dodaran M., Tohidi M., Firouzi F., Azizi F. Improving Prediction of Age at Menopause Using Multiple Anti-Müllerian Hormone Measurements: The Tehran Lipid-Glucose Study. J. Clin. Endocrinol. Metab. (2020). 105: dgaa083. DOI: 10.1210/clinem/dgaa083
13. Sowers M., Zheng H., Tomey K., Karvonen-Gutierrez C., Jannausch M., Li X. Changes in Body Composition in Women Over Six Years at Midlife: Ovarian and Chronological Aging. J. Clin. Endocrinol. Metab. (2007). 92:895–901. DOI: 10.1210/jc.2006–1393
14. Freeman E.W., Sammel M.D., Lin H., Gracia C.R. Anti-Mullerian Hormone as a Predictor of Time to Menopause in Late Reproductive Age Women. J. Clin. Endocrinol. Metab. (2012). 97:1673–80. DOI: 10.1210/jc.2011–3032
15. de Kat A.C., van der Schouw Y.T., Eijkemans M.J., Herber-Gast G.C., Visser J.A., Verschuren W.M. Back to the Basics of Ovarian Aging: A Population-Based Study on Longitudinal Anti-Mullerian Hormone Decline. BMC Med. (2016). 14:151. DOI:10.1186/s12916–016–0699-y
16. Moolhuijsen L.M.E., Visser J.A. Anti-MÃllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J. Clin. Endocrinol. Metab. (2020). 105:3361–73. DOI: 10.1210/clinem/dgaa513
17. Harlow S.D., Gass M., Hall J.E., Lobo R., Maki P., Rebar R.W. Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the Unfnished Agenda of Staging Reproductive Aging. J. Clin. Endocrinol. Metab. (2012). 97:1159–68. DOI: 10.1210/jc.2011–3362
18. Lambalk C.B., van Disseldorp J., de Koning C.H.., Broekmans FJ. Testing Ovarian Reserve to Predict Age at Menopause. Maturitas (2009). 63:280–91. DOI: 10.1016/j.maturitas.2009.06.007
19. van Rooij I.A., Broekmans F.J., Scheffer G.J., Looman C.W., Habbema J.D., de Jong F. H. Serum Antimullerian Hormone Levels Best Reflect the Reproductive Decline With Age in Normal Women With Proven Fertility: A Longitudinal Study. Fertil. Steril. (2005). 83:979–87. DOI: 10.1016/j.fertnstert.2004.11.029
20. Bertone-Johnson E.R., Manson J.E., Purdue-Smithe A.C., Steiner A.Z., Eliassen A.H., Hankinson S. E. Anti-Müllerian Hormone Levels and Incidence of Early Natural Menopause in a Prospective Study. Hum. Reprod. (2018). 33:1175–82. DOI: 10.1093/humrep/dey077
21. Anderson R.A., Nelson S.M. Anti-Müllerian Hormone in the Diagnosis and Prediction of Premature Ovarian Insuffciency. Semin. Reprod. Med. (2020). 38:263–9. DOI: 10.1055/s-0040–1722319
22. Elting M. W., Korsen T. J., Rekers-Mombarg L.T., Schoemaker J. Women With Polycystic Ovary Syndrome Gain Regular Menstrual Cycles When Ageing. Hum. Reprod. (2000). 15:24–8. DOI: 10.1093/humrep/15.1.24
23. van den Berg M.H., Overbeek A., Lambalk C.B., Kaspers G.J.L., Bresters D., van den Heuvel-Eibrink M.M. Long-Term Effects of Childhood Cancer Treatment on Hormonal and Ultrasound Markers of Ovarian Reserve. Hum. Reprod. (2018). 33:1474–88. DOI: 10.1093/humrep/dey229
24. Minooee S., Ramezani Tehrani F., Rahmati M., Mansournia M.A., Azizi F. Prediction of Age at Menopause in Women With Polycystic Ovary Syndrome. Climacteric. (2018). 21:29–34. DOI: 10.1080/13697137.2017.1392501
25. Streuli I., de Ziegler D., Gayet V., Santulli P., Bijaoui G., de Mouzon J. In Women With Endometriosis Anti-Müllerian Hormone Levels are Decreased Only in Those With Previous Endometrioma Surgery. Hum. Reprod. (2012). 27:3294–303. DOI: 10.1093/humrep/des274
26. Uncu G., Kasapoglu I., Ozerkan K., Seyhan A., Oral Yilmaztepe A., Ata B. Prospective Assessment of the Impact of Endometriomas and Their Removal on Ovarian Reserve and Determinants of the Rate of Decline in Ovarian Reserve. Hum. Reprod. (2013). 28:2140–5. DOI: 10.1093/humrep/det123
27. Younis J. S., Shapso N., Fleming R., Ben-Shlomo I., Izhaki I. Impact of Unilateral Versus Bilateral Ovarian Endometriotic Cystectomy on Ovarian Reserve: A Systematic Review and Meta-Analysis. Hum. Reprod. Update. (2019). 25:375–91. DOI: 10.1093/humupd/dmy049
28. Coccia M.E., Rizzello F., Mariani G., Bulletti C., Palagiano A., Scarselli G. Ovarian Surgery for Bilateral Endometriomas Influences Age at Menopause. Hum. Reprod. (2011) 26:3000–7. DOI: 10.1093/humrep/der286
29. Nielsen S.N., Andersen A.N., Schmidt K.T., Rechnitzer C., Schmiegelow K., Bentzen J.G. A 10-Year Follow Up of Reproductive Function in Women Treated for Childhood Cancer. Reprod BioMed Online (2013). 27:192–200. DOI: 10.1016/j.rbmo.2013.04.003
30. van der Kooi A.L., van den Heuvel-Eibrink M.M., van Noortwijk A., Neggers S.J., Pluijm S.M., van Dulmen-den Broeder E. Longitudinal Follow-Up in Female Childhood Cancer Survivors: No Signs of Accelerated Ovarian Function Loss. Hum. Reprod. (2017). 32:193–200. DOI: 10.1093/humrep/dew278
31. van Dorp W., van den Heuvel-Eibrink M.M., de Vries A. C., Pluijm S. M., Visser J. A., Pieters R. Decreased Serum Anti-Müllerian Hormone Levels in Girls With Newly Diagnosed Cancer. Hum. Reprod. (2014). 29:337–42. DOI: 10.1093/humrep/det442
32. Ruth K.S., Day F.R., Hussain J., Martínez-Marchal A., Aiken C.E., Azad A. Genetic Insights Into Biological Mechanisms Governing Human Ovarian Ageing. Nature (2021). 596(7872):393–7. DOI: 10.1038/s41586–021–03779–7
33. Laven J. S.E. Genetics of Menopause and Primary Ovarian Insuffciency: Time for a Paradigm Shift? Semin. Reprod. Med. (2020). 38:256–62. DOI: 10.1055/s-0040–1721796
34. Grootenhuis A., van den Hoogen A., Broekmans F., Torrance H., van Os-Medendorp H., Ockhuijsen H. Young Women’s Opinions on the Use of a Blood Test to Predict the Possibility of Premature Ovarian Failure: A Qualitative Study. Hum. Fertil. (Camb) (2019). 1–11. DOI: 10.1080/14647273.2019.1665198
35. Habbema J. D., Eijkemans M. J., Leridon H., te Velde E. R. Realizing a Desired Family Size: When Should Couples Start? Hum. Reprod. (2015). 30:2215–21. DOI:10.1093/humrep/dev148
36. de Kat A.C., Broekmans F.J.M., Lambalk C.B. Role of AMH in Prediction of Menopause Front Endocrinol (Lausanne). Published online 2021 Sep 14. DOI: 10.3389/fendo.2021.733731
Review
For citations:
Zaydieva Ya.Z. Is AMH Prediction of Menopause? Medical alphabet. 2023;(3):37-41. (In Russ.) https://doi.org/10.33667/2078-5631-2023-3-37-41
Views:
787
Email this article 